{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:45:53Z","timestamp":1781592353800,"version":"3.54.5"},"reference-count":76,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["35\/4\/2019\/NANO\/BMS"],"award-info":[{"award-number":["35\/4\/2019\/NANO\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/53\/2020\/NCD-III"],"award-info":[{"award-number":["5\/13\/53\/2020\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/7\/2019\/NCD-III"],"award-info":[{"award-number":["5\/13\/7\/2019\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["27(0347)\/19\/EMR-II"],"award-info":[{"award-number":["27(0347)\/19\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["JCB\/2019\/000008"],"award-info":[{"award-number":["JCB\/2019\/000008"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008984","name":"Indian Institute of Technology Kharagpur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbadis.2023.166782","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T15:54:46Z","timestamp":1685980486000},"page":"166782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition"],"prefix":"10.1016","volume":"1869","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-720X","authenticated-orcid":false,"given":"Moumita","family":"Kundu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8628-5128","authenticated-orcid":false,"given":"Subhayan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvendu","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibakar","family":"Dhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-3323","authenticated-orcid":false,"given":"Mahitosh","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166782_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phymed.2018.06.012","article-title":"Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway","volume":"49","author":"Chio","year":"2018","journal-title":"Phytomedicine."},{"key":"10.1016\/j.bbadis.2023.166782_bb0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-018-4267-z","article-title":"Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells","volume":"18","author":"Chio","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2023.166782_bb0015","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/ptr.6426","article-title":"Prospect of natural products in glioma: a novel avenue in glioma management","volume":"33","author":"Kundu","year":"2019","journal-title":"Phyther. Res."},{"key":"10.1016\/j.bbadis.2023.166782_bb0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbadis.2023.166782_bb0025","article-title":"Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by honokiol in glioblastoma multiforme cells","volume":"10","author":"Lai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166782_bb0030","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1002\/cam4.1551","article-title":"FM19G11 inhibits O6-methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions","volume":"7","author":"You","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbadis.2023.166782_bb0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jnc.14326","article-title":"Transcriptional control of O 6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma","volume":"144","author":"Happold","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2023.166782_bb0040","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1158\/0008-5472.CAN-06-3820","article-title":"Novel mechanism whereby nuclear factor \u03baB mediates DNA damage repair through regulation of O 6 -methylguanine-DNA-methyltransferase","volume":"67","author":"Lavon","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2023.166782_bb0045","first-page":"21","article-title":"Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells","author":"Yu","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbadis.2023.166782_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1479-5876-10-252","article-title":"NF-\u03baB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug","volume":"10","author":"Caporali","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2023.166782_bb0055","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-022-01194-y","article-title":"Regorafenib reverses temozolomide-induced CXCL12\/CXCR4 signaling and triggers apoptosis mechanism in glioblastoma","author":"Chiang","year":"2022","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.bbadis.2023.166782_bb0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/cns.13591","article-title":"Regulation of temozolomide resistance in glioma cells via the RIP2\/NF-\u03baB\/MGMT pathway","volume":"27","author":"Hu","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbadis.2023.166782_bb0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3892\/ijo.2015.3271","article-title":"Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-\u03baB-dependent pathway downregulating MGMT expression","volume":"48","author":"Lan","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0070","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/abe8f2","article-title":"Natural products based nanoformulations for cancer treatment: current evolution in Indian research","volume":"16","author":"Kundu","year":"2021","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.bbadis.2023.166782_bb0075","first-page":"1","article-title":"Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbadis.2023.166782_bb0080","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1021\/jf400542m","article-title":"P27\/Kip1 is responsible for Magnolol-induced U373 apoptosis in vitro and in vivo","volume":"61","author":"Chen","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2023.166782_bb0085","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1021\/jf901477g","article-title":"Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21\/Cip1","volume":"57","author":"Chen","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2023.166782_bb0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jnen\/nly021","article-title":"Magnolol inhibits human glioblastoma cell migration by regulating N-cadherin","volume":"77","author":"Cheng","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113488","article-title":"Magnolol induces cytotoxic autophagy in glioma by inhibiting PI3K\/AKT\/mTOR signaling","volume":"424","author":"Kundu","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2023.166782_bb0100","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1055\/s-0030-1271159","article-title":"Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats","volume":"77","author":"Lin","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.bbadis.2023.166782_bb0105","first-page":"3455","article-title":"The protective effects of magnolol on acute trinitrobenzene sulfonic acid-induced colitis in rats","volume":"17","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2023.166782_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molimm.2018.11.008","article-title":"Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-\u03baB signal pathways in vitro and in vivo","volume":"105","author":"Chen","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0115","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11011-017-0004-6","article-title":"Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro","volume":"32","author":"Liu","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbadis.2023.166782_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10753-014-0003-2","article-title":"Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model","volume":"38","author":"Wei","year":"2015","journal-title":"Inflammation."},{"key":"10.1016\/j.bbadis.2023.166782_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2012.05.038","article-title":"The effect of magnolol on the toll-like receptor 4\/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice","volume":"689","author":"Yunhe","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0130","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1021\/jf100601r","article-title":"Inhibitory effect of Magnolol on TPA-induced skin inflammation and tumor promotion in mice","volume":"58","author":"Kuo","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2023.166782_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4149\/neo_2020_200923N1010","article-title":"Magnolol suppressed cell migration and invasion and induced cell apoptosis via inhibition of the NF-\u03baB signaling pathway by upregulating microRNA-129 in multiple myeloma","volume":"68","author":"Jin","year":"2021","journal-title":"Neoplasma."},{"key":"10.1016\/j.bbadis.2023.166782_bb0140","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopha.2017.07.085","article-title":"Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-\u03baB signaling pathway","volume":"94","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2023.166782_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/tox.22853","article-title":"Apoptosis induction and ERK\/NF-\u03baB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo","volume":"35","author":"Tsai","year":"2020","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0150","first-page":"1004","article-title":"Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer","volume":"2019","author":"Das","year":"1866","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2023.166782_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2017.05.030","article-title":"Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma","volume":"402","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2023.166782_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114474","article-title":"Paracrine TGF-\u03b21 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44\/42 MAPK signaling pathway","volume":"186","author":"Chandra Jena","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101539","article-title":"A distinct expression pattern of cyclin K in mammalian testes suggests a functional role in spermatogenesis","volume":"9","author":"Xiang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166782_bb0170","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41388-018-0272-6","article-title":"Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo","volume":"37","author":"Parekh","year":"2018","journal-title":"Oncogene."},{"key":"10.1016\/j.bbadis.2023.166782_bb0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.onc.1209785","article-title":"Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine","volume":"26","author":"Roos","year":"2007","journal-title":"Oncogene."},{"key":"10.1016\/j.bbadis.2023.166782_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-60327-409-8_8","article-title":"Detection of DNA strand breaks in apoptotic cells by flow- and image-cytometry","volume":"682","author":"Darzynkiewicz","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1215\/15228517-2008-090","article-title":"Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts","volume":"11","author":"Kitange","year":"2009","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2023.166782_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/biomedicines5020029","article-title":"NF-\u03baB Signalling in Glioblastoma","volume":"5","author":"Soubannier","year":"2017","journal-title":"Biomedicines."},{"key":"10.1016\/j.bbadis.2023.166782_bb0195","doi-asserted-by":"crossref","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF- B family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0200","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1038\/sj.onc.1208842","article-title":"Betulinic acid as new activator of NF-\u03baB: molecular mechanisms and implications for cancer therapy","volume":"24","author":"Kasperczyk","year":"2005","journal-title":"Oncogene."},{"key":"10.1016\/j.bbadis.2023.166782_bb0205","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1463-1326.2011.01402.x","article-title":"JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence, Diabetes","volume":"13","author":"Kumar","year":"2011","journal-title":"Obes. Metab."},{"key":"10.1016\/j.bbadis.2023.166782_bb0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.febslet.2004.06.056","article-title":"Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-\u03baB without affecting I\u03baB degradation","volume":"571","author":"Shin","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2023.166782_bb0215","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/j.eujim.2011.09.002","article-title":"Magnolol: a multifunctional compound isolated from the Chinese medicinal plant Magnolia officinalis","volume":"3","author":"Chen","year":"2011","journal-title":"Eur. J. Integr. Med."},{"key":"10.1016\/j.bbadis.2023.166782_bb0220","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jnen\/nly021","article-title":"Magnolol inhibits human glioblastoma cell migration by regulating N-cadherin","volume":"77","author":"Cheng","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0225","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1021\/jf400542m","article-title":"P27\/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo","volume":"61","author":"Chen","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2023.166782_bb0230","doi-asserted-by":"crossref","first-page":"29116","DOI":"10.18632\/oncotarget.8674","article-title":"Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbadis.2023.166782_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2015.02.012","article-title":"The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells","volume":"360","author":"Lee","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2023.166782_bb0240","doi-asserted-by":"crossref","first-page":"12324","DOI":"10.1073\/pnas.1921531117","article-title":"Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma","volume":"117","author":"Rajesh","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2023.166782_bb0245","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.3390\/molecules24183230","article-title":"SB365, Pulsatilla Saponin D induces caspase-independent cell death and augments the anticancer effect of Temozolomide in glioblastoma multiforme cells","volume":"24","author":"Hong","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.bbadis.2023.166782_bb0250","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-017-2387-y","article-title":"Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition","volume":"132","author":"Zhang","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0255","first-page":"1","article-title":"Lovastatin enhances cytotoxicity of Temozolomide via impairing autophagic flux in glioblastoma cells","volume":"2019","author":"Zhu","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbadis.2023.166782_bb0260","doi-asserted-by":"crossref","unstructured":"B. Kaina, Temozolomide in glioblastoma therapy: role of apoptosis, senescence and autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69, Biomedicines. 7 (2019) 90. doi:https:\/\/doi.org\/10.3390\/biomedicines7040090.","DOI":"10.3390\/biomedicines7040090"},{"key":"10.1016\/j.bbadis.2023.166782_bb0265","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ijc.31912","article-title":"Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide","volume":"144","author":"Johannessen","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2023.166782_bb0270","first-page":"1185","article-title":"AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-\u03baB and AKT pathways","volume":"11","author":"Han","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbadis.2023.166782_bb0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1126\/scitranslmed.aar2238","article-title":"BCL3 expression promotes resistance to alkylating chemotherapy in gliomas","volume":"10","author":"Wu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2023.166782_bb0280","article-title":"Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma","volume":"19","author":"Barone","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2023.166782_bb0285","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1007\/s11064-016-2043-5","article-title":"Histone deacetylase inhibitor RGFP109 overcomes Temozolomide resistance by blocking NF-\u03baB-dependent transcription in glioblastoma cell lines","volume":"41","author":"Li","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2023.166782_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20181711","article-title":"Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"38","author":"Zhang","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbadis.2023.166782_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116917","article-title":"Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor \u03baB pathway","volume":"236","author":"Yu","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2023.166782_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113854","article-title":"Antineoplastic effect of decoy oligonucleotide derived from MGMT enhancer","volume":"9","author":"Canello","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166782_bb0305","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.molimm.2006.12.004","article-title":"Magnolol suppresses NF-\u03baB activation and NF-\u03baB regulated gene expression through inhibition of IkappaB kinase activation","volume":"44","author":"Tse","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0310","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.intimp.2008.08.018","article-title":"Signaling pathway for TNF-\u03b1-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells","volume":"8","author":"Lee","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0315","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1038\/srep03098","article-title":"The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy","volume":"3","author":"Liu","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2023.166782_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.620677","article-title":"Drug resistance in glioblastoma: the two faces of oxidative stress","volume":"7","author":"Olivier","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbadis.2023.166782_bb0325","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","article-title":"Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2023.166782_bb0330","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3892\/ijo.2013.1959","article-title":"Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K\/AKT\/mTOR signaling pathway in mES\/EB-derived endothelial-like cells","volume":"43","author":"Kim","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2018.04.033","article-title":"Inhibition of NF-\u03baB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression","volume":"428","author":"Yu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2023.166782_bb0340","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s12094-019-02251-3","article-title":"IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma","volume":"22","author":"Guo","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0345","first-page":"6597","article-title":"BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K\/Akt\/NF-\u03baB\/MGMT signaling pathway","volume":"14","author":"Li","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2023.166782_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154016","article-title":"Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K\/Akt\/mTOR\/NF-\u03baB-mediated signaling pathway","volume":"99","author":"Tang","year":"2022","journal-title":"Phytomedicine."},{"key":"10.1016\/j.bbadis.2023.166782_bb0355","doi-asserted-by":"crossref","first-page":"ii39","DOI":"10.1093\/neuonc\/noab180.135","article-title":"P14.09 BORTEM-17: a phase IB\/II single-arm, control non-randomized, multicentre, open label clinical trial for recurrent glioblastoma with unmethylated MGMT promoter (NCT03643549)","volume":"23","author":"Goplen","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2023.166782_bb0360","doi-asserted-by":"crossref","first-page":"22493","DOI":"10.1002\/jcp.28813","article-title":"Neuropathological and genomic characterization of glioblastoma-induced rat model: how similar is it to humans for targeted therapy?","volume":"234","author":"Sharifzad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0365","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2023.166782_bb0370","article-title":"Temozolomide treatment induces HMGB1 to promote the formation of glioma stem cells via the TLR2\/NEAT1\/Wnt pathway in glioblastoma","volume":"9","author":"Gao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175388","article-title":"MicroRNA-based therapy for glioblastoma: opportunities and challenges","volume":"938","author":"Lei","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166782_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drup.2018.03.003","article-title":"Glioblastoma cancer stem cell biology: potential theranostic targets","volume":"42","author":"Sharifzad","year":"2019","journal-title":"Drug Resist. Updat."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:39:05Z","timestamp":1727761145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0925443923001485"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166782","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166782"}}